Approvals/TGA/SIFROL ER pramipexole dihydrochloride monohydrate 0.75 mg extended-release tablet blister pack

Approved

STANDARD

SIFROL ER pramipexole dihydrochloride monohydrate 0.75 mg extended-release tablet blister pack

Boehringer Ingelheim Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 8b10fd9a2af1d8a6
Product Name: SIFROL ER pramipexole dihydrochloride monohydrate 0.75 mg extended-release tablet blister pack
Artg Id: 158755
Artg Name: SIFROL ER pramipexole dihydrochloride monohydrate 0.75 mg extended-release tablet blister pack
Sponsor: Boehringer Ingelheim Pty Ltd
Company Detail Path: /organization/boehringer-ingelheim-pty-ltd
Artg Date: 2010-03-26
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-04388-3
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-03631-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

8b10fd9a2af1d8a6

Type

Standard